TFF Pharmaceuticals, Inc. (TFFP) has 55 open-market insider trades by 13 insiders since 2019. The most active filer is Kirk Allen Coleman, CFO & Secretary +1.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Lung Therapeutics, Inc. | 10% Owner | — | 2 | $24.6M | 2021-03-26 |
| Glenn R. Mattes | CEOPres | — | 8 | $4.6M | 2022-05-16 |
| Aaron G.l. Fletcher | Dir | — | 8 | $4.5M | 2022-11-22 |
| Malcolm Fairbairn | Dir | — | 2 | $2.5M | 2021-05-19 |
| Robert S. Mills | Dir | — | 4 | $2.0M | 2024-07-03 |
| Stephen Rocamboli | Dir | — | 5 | $1.8M | 2024-07-03 |
| Randy H. Thurman | Dir | — | 4 | $1.6M | 2022-09-29 |
| Kirk Allen Coleman | CFOSecretaryTreasurer | — | 10 | $670K | 2024-07-03 |
| James Brian Windsor | CSO | — | 2 | $420K | 2020-12-07 |
| Harlan F. Weisman | CEOPres | — | 6 | $410K | 2024-07-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Brandi Roberts | Director | Buy | $5K | 2023-08-15 |
| Zamaneh Mikhak | Chief Medical Officer | Buy | $30K | 2023-08-15 |
| Clint Duane Carlson | 10% Owner | Sell | $95K | 2023-08-15 |
| Harlan F. Weisman | CEO & President | Buy | $150K | 2023-08-15 |
| Robert S. Mills | Director | Buy | $10K | 2023-08-15 |
| Stephen Rocamboli | Director | Buy | $10K |
Companies that share insiders with TFFP, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-03-10 |
| Harlan F. Weisman | CEO & President | Buy | $132K | 2023-03-10 |
| Zamaneh Mikhak | Chief Medical Officer | Buy | $12K | 2023-03-10 |
| Kirk Allen Coleman | CFO | Buy | $9K | 2023-03-10 |
| Harlan F. Weisman | CEO & President | Buy | $53K | 2022-12-15 |
| Aaron G.l. Fletcher | Director | Buy | $50K | 2022-11-22 |
| Randy H. Thurman | Director | Sell | $345K | 2022-09-29 |
| Harlan F. Weisman | Director | Buy | $38K | 2022-05-18 |
| Aaron G.l. Fletcher | Director | Buy | $538K | 2022-05-16 |
| Glenn R. Mattes | CEO & President | Buy | $76K | 2022-05-16 |